ArticleFrontiers in oncology2024

Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: a case report.

Zhedong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.